Clinical Trial Update: Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating screening for hepatocellular carcinoma in patients with compensated cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Compensated Cirrhosis
• Hepatocellular Carcinoma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Compensated Cirrhosis | Phase 3 | Status: COMPLETED